company background image
623 logo

Jilin Aodong Pharmaceutical Group SZSE:000623 Stock Report

Last Price

CN¥13.94

Market Cap

CN¥16.7b

7D

-0.07%

1Y

-14.8%

Updated

14 Jun, 2024

Data

Company Financials +

Jilin Aodong Pharmaceutical Group Co., Ltd.

SZSE:000623 Stock Report

Market Cap: CN¥16.7b

Jilin Aodong Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jilin Aodong Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥13.94
52 Week HighCN¥18.17
52 Week LowCN¥13.13
Beta0.43
1 Month Change-6.13%
3 Month Change-6.76%
1 Year Change-14.84%
3 Year Change-9.01%
5 Year Change-17.12%
Change since IPO355.78%

Recent News & Updates

Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Jun 03
Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Apr 23
There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Recent updates

Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Jun 03
Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Apr 23
There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Shareholder Returns

623CN PharmaceuticalsCN Market
7D-0.07%-0.7%-0.07%
1Y-14.8%-11.9%-15.5%

Return vs Industry: 000623 underperformed the CN Pharmaceuticals industry which returned -11.9% over the past year.

Return vs Market: 000623 matched the CN Market which returned -15.5% over the past year.

Price Volatility

Is 623's price volatile compared to industry and market?
623 volatility
623 Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.2%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 000623 has not had significant price volatility in the past 3 months.

Volatility Over Time: 000623's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19575,646Shuqin Guowww.jlaod.com

Jilin Aodong Pharmaceutical Group Co., Ltd. produces and sells pharmaceutical products in China. The company offers various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine.

Jilin Aodong Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Jilin Aodong Pharmaceutical Group's earnings and revenue compare to its market cap?
623 fundamental statistics
Market capCN¥16.67b
Earnings (TTM)CN¥1.12b
Revenue (TTM)CN¥3.52b

14.9x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
623 income statement (TTM)
RevenueCN¥3.52b
Cost of RevenueCN¥1.88b
Gross ProfitCN¥1.64b
Other ExpensesCN¥520.97m
EarningsCN¥1.12b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.93
Gross Margin46.52%
Net Profit Margin31.73%
Debt/Equity Ratio5.9%

How did 623 perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

60%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.